Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

EXP 597 MeSH Supplementary Concept Data 2025


MeSH Supplementary
EXP 597
Unique ID
C090811
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C090811
Entry Term(s)
1H-Imidazole-5-carboxylic acid, 4-ethyl-1-((3-fluoro-2'-((((((3-methylbutoxy)carbonyl)amino)sulfonyl))1,1'-biphenyl)-4-yl)methyl)-2-propyl-, (2-benzoylphenyl)methyl ester
4-((5-(2-benozyl)benzyloxycarbonyl-4-ethyl-2-n-propylimidazole-1-yl)methyl)-3-fluoro-2'-isoamyloxycarbonylaminosulfonyl-1,1'-biphenyl
EXP-597
EXP597
Registry Numbers
157566-60-4
Heading Mapped to
*Imidazoles
*Sulfonamides
Frequency
2
Note
to search, use E#P 597(nm); an angiotensin II receptor antagonist; structure in first source
Source
Eur J Pharmacol 1994 Aug 1;260(2-3):261-4
Date of Entry
1995/01/06
Revision Date
2005/10/13
EXP 597 Preferred
4-((5-(2-benozyl)benzyloxycarbonyl-4-ethyl-2-n-propylimidazole-1-yl)methyl)-3-fluoro-2'-isoamyloxycarbonylaminosulfonyl-1,1'-biphenyl Broader
page delivered in 0.004s